X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (75) 75
index medicus (73) 73
cardiac & cardiovascular systems (63) 63
female (56) 56
male (47) 47
aged (36) 36
risk factors (35) 35
middle aged (33) 33
mortality (32) 32
abridged index medicus (28) 28
heart failure (20) 20
treatment outcome (19) 19
outcomes (18) 18
risk (17) 17
acute coronary syndromes (16) 16
prevention (16) 16
research (16) 16
adult (15) 15
cardiovascular disease (15) 15
myocardial infarction (14) 14
myocardial-infarction (14) 14
studies (14) 14
acute myocardial-infarction (13) 13
cardiovascular (13) 13
diabetes mellitus, type 2 - drug therapy (13) 13
medicine, general & internal (13) 13
analysis (12) 12
cardiac patients (12) 12
events (12) 12
heart attacks (12) 12
diabetes (11) 11
diabetes mellitus (11) 11
prospective studies (11) 11
stroke (11) 11
acute coronary syndrome (10) 10
cardiovascular diseases (10) 10
disease (10) 10
metaanalysis (10) 10
randomized controlled trials as topic (10) 10
cardiology (9) 9
cardiovascular diseases - epidemiology (9) 9
diabetes mellitus, type 2 - complications (9) 9
follow-up studies (9) 9
health aspects (9) 9
heart-failure (9) 9
hospitalization (9) 9
hospitals (9) 9
management (9) 9
patients (9) 9
women (9) 9
animals (8) 8
association (8) 8
clinical trials (8) 8
cohort studies (8) 8
endocrinology & metabolism (8) 8
epidemiology (8) 8
health risk assessment (8) 8
heart diseases (8) 8
hypoglycemic agents - adverse effects (8) 8
incidence (8) 8
prognosis (8) 8
time factors (8) 8
aged, 80 and over (7) 7
cardiovascular diseases - etiology (7) 7
care and treatment (7) 7
coronary heart disease (7) 7
drug therapy (7) 7
heart (7) 7
heart attack (7) 7
hypoglycemic agents - therapeutic use (7) 7
intervention (7) 7
medical research (7) 7
ontario (7) 7
patient outcomes (7) 7
percutaneous coronary intervention (7) 7
peripheral vascular disease (7) 7
registries (7) 7
retrospective studies (7) 7
survival (7) 7
trial (7) 7
womens health (7) 7
acute coronary syndrome - therapy (6) 6
article (6) 6
cardiovascular diseases - mortality (6) 6
cardiovascular diseases - prevention & control (6) 6
dosage and administration (6) 6
physiological aspects (6) 6
prevalence (6) 6
proportional hazards models (6) 6
research article (6) 6
risk assessment (6) 6
risk-factors (6) 6
therapy (6) 6
transplantation (6) 6
united-states (6) 6
acute coronary syndrome - diagnosis (5) 5
acute coronary syndrome - mortality (5) 5
biology (5) 5
cardiology and cardiovascular medicine (5) 5
cardiovascular outcomes (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 10/2017, Volume 136, Issue 17, pp. 1643 - 1658
Journal Article
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ISSN 0735-1097, 07/2019, Volume 74, Issue 4, pp. 536 - 537
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1317 - 1326
Saxagliptin, a new oral antihyperglycemic drug in the DPP-4 inhibitor class, had no effect on the risk of cardiovascular events in patients with type 2... 
ALL-CAUSE | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | EVENTS | GLUCOSE CONTROL | MICROALBUMINURIA | DISEASE | CLINICAL-USE | PREVENTION | RISK | DEATH | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Adamantane - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Hypoglycemia - chemically induced | Heart Failure - epidemiology | Diabetes Mellitus, Type 2 - complications | Adamantane - adverse effects | Adamantane - analogs & derivatives | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Dipeptides - therapeutic use | Double-Blind Method | Pancreatitis - epidemiology | Dipeptides - adverse effects | Kaplan-Meier Estimate | Pancreatitis - chemically induced | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Patient outcomes | Dosage and administration | Drug therapy | Heart diseases | Risk factors | Saxagliptin | Myocardial infarction | Cerebral infarction | Heart attacks | Peptidase | Diabetes mellitus | Pancreatitis | Cardiovascular disease | Angina | Patients | Heart rate | Ischemia | Diabetes | Cardiovascular diseases | Diabetes mellitus (non-insulin dependent)
Journal Article
DIABETES CARE, ISSN 0149-5992, 04/2015, Volume 38, Issue 4, pp. 696 - 705
Journal Article
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, ISSN 0098-7484, 02/2018, Volume 319, Issue 5, pp. 505 - 505
Journal Article
Journal Article
CANADIAN JOURNAL OF DIABETES, ISSN 1499-2671, 03/2019, Volume 43, Issue 2, pp. 154 - 154
Journal Article
Circulation, ISSN 0009-7322, 2014, Volume 130, Issue 18, pp. 1579 - 1588
Journal Article
Journal Article
Canadian Journal of Cardiology, ISSN 0828-282X, 03/2018, Volume 34, Issue 3, pp. 214 - 233
Journal Article